CMS proposes a faster pathway for manufacturers to obtain Medicare coverage of new medical devices.
US CMS Newsroom · United StatesFinal rules amend price transparency requirements for non-grandfathered group and individual health plans, standardizing machine-readable pricing files with new data elements and reporting thresholds.
US Federal Register - HHS Rules · United StatesProposed requirements for electronic prior authorization for drugs and extended interoperability standards across Medicare Advantage, Medicaid, CHIP, and QHP issuers.
US Federal Register - CMS Rules · United StatesNICE adapts its evidence standards framework for digital health technologies to support decision-making for digital care technologies in adult social care.
UK NICE · UKIDAP pilot accelerates development and market integration of innovative medical devices addressing unmet NHS clinical needs.
UK MHRA · UKCommission adopts rules enabling joint clinical assessments of medical devices and IVDs under the HTA Regulation.
EC Public Health · EU-wideUpdated guidance and eligibility tool published to support early information provision for joint clinical assessments under the EU HTA Regulation.
EC Public Health · EU-wideINFARMED publishes initial FAQ clarifying changes to Portugal's National Health Technology Assessment System (SiNATS) introduced by Decree-Law 118/2026.
Portugal INFARMED · PortugalFinal rule establishing transparency requirements for healthcare pricing information to patients, implementing Executive Order 14221.
US CMS Newsroom · United StatesCMS announced new regulations to improve access to reliable, accessible healthcare pricing and coverage information.
US CMS Newsroom · United StatesPharmaceutical product repricing list for 2026 with additions and deletions published under existing ministerial decision.
Greece EOF · GreeceList establishes reimbursement prices, maximum manufacturer prices, and reimbursement conditions for categorised and non-categorised foods for special medical purposes covered by public health insurance.
Czechia SUKL · Czech RepublicCMS implements mandatory Medicare payment model testing alternative drug inflation rebate calculation for Part B drugs to reduce costs.
US Federal Register - CMS Rules · United StatesCMS finalizes a mandatory drug payment model to address rising drug costs in Original Medicare Part B.
US CMS Newsroom · United StatesCollection of joint clinical assessment reports, procedural guidance for scientific consultations on devices and IVDs, AI principles, and methodological FAQs for HTA implementation.
EU HTA Regulation Implementation · EU-wideCollection of joint clinical assessment reports, procedural guidance for joint scientific consultations on devices and IVDs, and methodological Q&As for HTA dossier preparation.
EU HTA Regulation Implementation · EU-wideRevised draft guidance on manufacturer communications of health care economic information about approved drugs and devices to payors and formulary committees.
US Federal Register - FDA Guidance Notices · United StatesUpdated guidance on methodology and procedure for joint clinical assessments under the EU HTA Regulation.
EC Public Health · EU-wideGuidance clarifying methodological and procedural requirements for joint clinical assessments under the EU HTA Regulation.
EC Public Health · EU-wideCzech SUKL publishes the official list of prices and reimbursements for medicinal products under public health insurance.
Czechia SUKL · Czech RepublicGreece publishes corrected final proposed pharmaceutical prices for Q2 2026, including repricing of reference products following data protection expiry and adjustment of non-reimbursed product prices.
Greece EOF · GreeceThree templates published to standardise written input from patients, carers and clinicians in joint HTA clinical assessments, developed with stakeholder consultation.
EU HTA Regulation Implementation · EU-wideGuidance on applying for New Active Substance Work Sharing Initiative and Biosimilar Work Sharing Initiative assessments with list of approved products.
UK MHRA · UKCMS proposes reforms to improve provider directory accuracy in Medicare Advantage plans and establish transparency requirements.
US CMS Newsroom · United StatesGreece publishes a revised list of reimbursed medicines under Law 4512/2018 for public consultation.
Greece EOF · GreeceCMS solicits input on standards for reasonable and relevant pharmacy contract terms under Medicare Part D, effective plan year 2029.
US Federal Register - CMS Rules · United StatesNICE invites input on adopting a new EQ-5D-5L value set to improve health-related quality-of-life assessments in treatment evaluation.
UK NICE · UKJoint Clinical Assessments under the HTA Regulation now extend to selected high-risk medical devices and in-vitro diagnostics.
European Commission · EU-wideFDA finalizes guidance on therapeutic equivalence evaluations and TE codes for multisource prescription drug products in the Orange Book.
US Federal Register - FDA Notices · United StatesFactsheets on joint clinical assessment and scientific consultation procedures under the EU HTA Regulation, plus implementation guidance and analysis of regional cooperation structures.
EU HTA Regulation Implementation · EU-wideDenmark's national basic medicines list for general practitioners expanded to include anxiety, smoking cessation, migraine and type 2 diabetes, consolidating regional lists.
Medicinrådet (Danish Medicines Council) · DenmarkILAP is a pathway to accelerate regulatory approval and NHS access for transformative new medicines.
UK MHRA · UKList of homogeneous groups and unit reference prices for Q4 2026 approved and effective 1 October 2026.
Portugal INFARMED · PortugalUpdated list of medicinal products reimbursed from public health insurance, incorporating SUKL and Ministry of Health decisions effective by 15 September 2026.
Czechia SUKL · Czech RepublicList establishes reimbursement prices, maximum manufacturer prices, and reimbursement conditions for categorised and non-categorised foods for special medical purposes covered by public health insurance.
Czechia SUKL · Czech RepublicGuidance document explaining how to complete applications for changes to reimbursement levels, conditions, and maximum manufacturer prices for medicines in Czechia.
Czechia SUKL · Czech RepublicGuidance document on completing applications for pharmaceutical reimbursement, conditions of coverage, and manufacturer maximum pricing in Czechia.
Czechia SUKL · Czech RepublicThe list of homogeneous groups and unit reference prices for Q3 2026 under Portugal's reference pricing system has been updated.
Portugal INFARMED · PortugalUpdated list of medicinal products reimbursed from public health insurance, incorporating SUKL and Ministry of Health decisions effective by 15 August 2026.
Czechia SUKL · Czech RepublicList establishes reimbursement prices, maximum manufacturer prices, and reimbursement conditions for categorised and non-categorised foods for special medical purposes covered by public health insurance.
Czechia SUKL · Czech RepublicNICE recommends an online therapy programme for people aged 16 and over with eating disorders awaiting specialist NHS treatment.
UK NICE · UKNICE conditionally recommends five AI technologies as decision-support tools during bowel examinations to improve early detection of precancerous growths.
UK NICE · UKCMS proposes updates to physician fee schedule, Part B payment policies, Medicare Shared Savings Program, Quality Payment Program, and Promoting Interoperability Program for calendar year 2027.
US Federal Register - CMS Rules · United StatesCzech SUKL publishes the official list of prices and reimbursements for medicinal products under public health insurance.
Czechia SUKL · Czech RepublicSUKL publishes a corrected list of prices and reimbursements for medicinal products under the public health insurance law.
Czechia SUKL · Czech RepublicCzech SUKL publishes the official list of prices and reimbursement rates for medicinal products under public health insurance.
Czechia SUKL · Czech RepublicCzech SUKL publishes the official price and reimbursement list for foods for special medical purposes under public health insurance.
Czechia SUKL · Czech RepublicFinal rule revises Medicare Advantage, Prescription Drug Benefit, and cost plan regulations for Star Ratings, marketing, drug coverage, and enrollment.
US Federal Register - CMS Rules · United StatesIQWiG General Methods 8.0 entered force in December 2025, introducing new methods for hospital minimum volume standards and HTA assessment.
IQWiG (German HTA) · GermanyGuidance clarifying joint clinical assessment procedures under the EU HTA Regulation.
EU HTA Regulation Implementation · EU-wide